Nuo Therapeutics, Inc. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Nuo Therapeutics, Inc. (AURX) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $18.76 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2014-03-31
- Nuo Therapeutics, Inc. business combination, consideration transferred, equity interests issued and issuable for fiscal 2013 was $18.76M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|
| 2013-12-31 | $18.76M 10-K · filed 2014-03-31 |